AstraZeneca (AZN) shares rose 3.5% in premarket trading Friday after the British drugmaker reported stronger-than-expected third-quarter earnings, driven by robust growth in its oncology business.
CryptoAlerta — análise de criptomoedas e mercado em tempo real